Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Olema Pharmaceuticals (OLMA) Leases (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Leases data on record, last reported at $921000.0 in Q1 2026.

  • On a quarterly basis, Leases fell 12.7% to $921000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $921000.0, a 12.7% decrease, with the full-year FY2025 number at $1.1 million, down 12.79% from a year prior.
  • Leases reached $921000.0 in Q1 2026 per OLMA's latest filing, down from $1.1 million in the prior quarter.
  • Over the last five years, Leases for OLMA hit a ceiling of $3.0 million in Q2 2022 and a floor of $921000.0 in Q1 2026.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: decreased 6.4% in 2024, then crashed 48.66% in 2025.
  • Tracing OLMA's Leases over 5 years: stood at $2.5 million in 2022, then fell by 8.18% to $2.3 million in 2023, then tumbled by 42.65% to $1.3 million in 2024, then fell by 12.79% to $1.1 million in 2025, then dropped by 19.63% to $921000.0 in 2026.
  • Business Quant data shows Leases for OLMA at $921000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.